Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ats907 (2 trials)
timolol (blocadren) (1 trial)
Glaucoma (Phase 2)
Glaucoma, Open-Angle (Phase 2)
Hypertension (Phase 2)
Ocular Hypertension (Phase 2)
Trials (2 total)
Trial APIs (2 total)